Theravance Biopharma, Inc.TBPHNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank7
3Y CAGR-34.9%
5Y CAGR-29.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-34.9%/yr
vs -8.8%/yr prior
5Y CAGR
-29.8%/yr
Recent deceleration
Acceleration
-26.1pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $18.52M | -73.2% |
| 2024 | $69.17M | -1.8% |
| 2023 | $70.45M | +5.0% |
| 2022 | $67.07M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $108.53M | +2.3% |
| 2019 | $106.08M | +9.3% |
| 2018 | $97.06M | +1.5% |
| 2017 | $95.59M | +13.1% |
| 2016 | $84.51M | - |